Kieran Docherty
University of Glasgow
H-index: 36
Europe-United Kingdom
Top articles of Kieran Docherty
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Review of the National Institute for Health and Care Excellence guidelines on chronic heart failure | Pier D Lambiase Edd Maclean | 2024/3/1 | |
Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure | International Journal of Cardiology | Caroline Espersen Ross T Campbell Brian L Claggett Eldrin F Lewis Kieran F Docherty | 2024/4/8 |
Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF | Journal of the American College of Cardiology | Toru Kondo Ulrik M Mogensen Atefeh Talebi Samvel B Gasparyan Ross T Campbell | 2024/3/25 |
Intravenous iron and SGLT2 inhibitors in iron‐deficient patients with heart failure and reduced ejection fraction | ESC Heart Failure | Kieran F Docherty John JV McMurray Paul R Kalra John GF Cleland Ninian N Lang | 2024 |
Effect of dapagliflozin versus placebo on symptoms and 6-minute walk distance in patients with heart failure: The determine randomized clinical trials | Circulation | John JV McMurray Kieran F Docherty Rudolf A de Boer Ann Hammarstedt Dalane W Kitzman | 2024/3/12 |
Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights from REVIVED-BCIS2 | JACC: Heart Failure | Matthew Ryan Dylan Taylor Matthew Dodd John A Spertus Mikhail N Kosiborod | 2024/4/8 |
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies | European Heart Journal-Cardiovascular Pharmacotherapy | Joanna Osmanska Katriona Brooksbank Kieran F Docherty Stacy Robertson Kirsty Wetherall | 2024/1 |
Wearable Sensors to Monitor Physical Activity in Heart Failure Clinical Trials: State-of-the-Art Review | Ruben Buendia Martin Karpefors Folke Folkvaljon Robert Hunter Henrik Sillen | 2024/3/5 | |
Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER | JACC: Heart Failure | Jawad H Butt Pardeep S Jhund Kieran F Docherty Brian L Claggett Muthiah Vaduganathan | 2024/4/3 |
The effect of omecamtiv mecarbil in hospitalized patients as compared with outpatients with HFrEF: an analysis of GALACTIC-HF | Journal of Cardiac Failure | Kieran F Docherty John JV McMurray Rafael Diaz G Michael Felker Marco Metra | 2024/1/1 |
Effect of neprilysin inhibition on alzheimer disease plasma biomarkers: a secondary analysis of a randomized clinical trial | JAMA neurology | Wagner S Brum Kieran F Docherty Nicholas J Ashton Henrik Zetterberg Oskar Hansson | 2024/2/1 |
THE EFFECT OF DAPAGLIFLOZIN ON DAYS OF FULL HEALTH LOST DUE TO DEATH, HOSPITALIZATION, AND IMPAIRED WELL-BEING IN DAPA-HF | Journal of the American College of Cardiology | Toru Kondo Ulrik Madvig Mogensen Atefeh Talebi Samvel Gasparyan ross campbell | 2024/4/2 |
Decline in estimated glomerular filtration rate after dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: a prespecified secondary analysis of … | JAMA cardiology | Finnian R Mc Causland Brian L Claggett Muthiah Vaduganathan Akshay Desai Pardeep Jhund | 2024/2/1 |
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction | JAMA cardiology | Kirsty McDowell Toru Kondo Atefeh Talebi Ken Teh Erasmus Bachus | 2024/3/27 |
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design | ESC Heart Failure | Jaclyn Carberry Mark C Petrie Matthew MY Lee Katriona Brooksbank Ross T Campbell | 2024/4/12 |
Dapagliflozin and kidney outcomes in patients with heart failure with mildly reduced or preserved ejection fraction: a prespecified analysis of the DELIVER randomized clinical … | JAMA cardiology | Finnian R Mc Causland Brian L Claggett Muthiah Vaduganathan Akshay S Desai Pardeep Jhund | 2023/1/1 |
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics | European Heart Journal | Su Ern Yeoh Joanna Osmanska Mark C Petrie Katriona JM Brooksbank Andrew L Clark | 2023/8/14 |
THE EFFECT OF DAPAGLIFLOZIN ON INSULIN INITIATION OR INTENSIFICATION IN PATIENTS IN HEART FAILURE AND DIABETES: A POOLED ANALYSIS OF DAPA-HF AND DELIVER | Journal of the American College of Cardiology | John JV McMurray Kieran F Docherty Pardeep Jhund Brian Claggett Rudolf A De Boer | 2023/3/7 |
Effect of dapagliflozin on outpatient worsening heart failure in patients with mildly reduced or preserved ejection fraction: the DELIVER trial | European Heart Journal | S Chatur M Vaduganathan BL Claggett AS Desai KF Docherty | 2023/11 |
Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol | Cerebrovascular Diseases | Alan C Cameron Georgios Katsas Markus Arnold Kieran Docherty Ross T Campbell | 2023/4/24 |
